N	Concordance
1	inoma? Forty-six patients with advanced anaplastic thyroid carcinoma were 
2	ency of incidence of differentiated and anaplastic thyroid carcinoma have 
3	      igh doses for multidrug-resistant anaplastic thyroid carcinoma cell lines.
4	   ifen on estrogen    receptor-lacking anaplastic thyroid carcinoma cell lines.
5	      ne were studied in vitro using 10 anaplastic thyroid carcinoma cell lines 
6	c thyroid carcinoma. Like patients with anaplastic thyroid carcinoma, few surviv
7	 or a single case each of medullary and anaplastic thyroid carcinoma. Telomerase
8	      rvival for patients with advanced anaplastic thyroid carcinoma. In conclus
9	f p53 point mutations has been found in anaplastic thyroid carcinomas but not in